YOU ARIYOSHI Sleep Clinic
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Motohiro, Ozone
NCT04742699: An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Completed
4
97
Japan
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant (LEM) 5 mg (SUV-combination cohort), Lemborexant (LEM) 5 mg (RMT-combination cohort)
Kurume University, Eisai Inc., Mebix Inc
Insomnia
06/22
06/22
Yu, Ariyoshi
NCT04742699: An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Completed
4
97
Japan
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant (LEM) 5 mg (SUV-combination cohort), Lemborexant (LEM) 5 mg (RMT-combination cohort)
Kurume University, Eisai Inc., Mebix Inc
Insomnia
06/22
06/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Motohiro, Ozone
NCT04742699: An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Completed
4
97
Japan
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant (LEM) 5 mg (SUV-combination cohort), Lemborexant (LEM) 5 mg (RMT-combination cohort)
Kurume University, Eisai Inc., Mebix Inc
Insomnia
06/22
06/22
Yu, Ariyoshi
NCT04742699: An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Completed
4
97
Japan
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant (LEM) 5 mg (SUV-combination cohort), Lemborexant (LEM) 5 mg (RMT-combination cohort)
Kurume University, Eisai Inc., Mebix Inc
Insomnia
06/22
06/22

Download Options